Presented by Julia Malkowski, ND, DC | July 2, 2025 at 12 PM Pacific

Methylation is a fundamental biochemical process with far-reaching implications for human health. This presentation will offer an in-depth exploration of methylation, its clinical significance, and the impact of methylation imbalances on health outcomes.

Methylation is involved in cardiovascular health, detoxification, neurotransmitter synthesis, hormone metabolism, DNA expression, immune modulation and fetal development. Analyzing key methylation biomarkers provides valuable insight into human physiology. Plasma levels of methionine, s-Adenosyl methionine (SAM), s-Adenosyl homocysteine (SAH), homocysteine, cystathionine and cysteine provide a functional assessment of the methylation cycle. Attendees will walk away with an understating of these biomarkers, enhanced understanding of methylation dynamics and their impact on clinical outcomes.

Learning Objectives:

• Understand the role of methylation in human physiology
• Comprehend objective biomarkers of the methylation cycle, including the methylation ratio, methionine, SAM, SAH, homocysteine, cystathionine and cysteine
• Explore the clinical significance of methylation imbalances
• Discuss case applications and therapeutic strategies based on methylation status

Starts July 21, 2025

Join Lylen Ferris, ND, Julia Malkowski, ND, DC, Jeannie Gorman, MS, CCN, and Laura Neville, ND for a 6-week immersive bootcamp designed to help you master the GI360™ test-combining advanced microbiome analysis with comprehensive digestive function assessment.

This bootcamp offers a clinical deep dive into interpreting commensals, pathogens, and biomarkers of digestion, inflammation, and immune activation-translating lab data into targeted, root-cause treatment strategies for GI-driven chronic conditions.

Learning Objectives:

• Comprehensive interpretation strategies for GI360™ results-including microbiome diversity, pathogenic bacteria, dysbiosis patterns, and digestive function markers (e.g., elastase, SCFAs, steatocrit).
• Root-cause connections between GI findings and systemic conditions like autoimmunity, metabolic dysfunction, and neuroinflammation.
• Evidence-based protocols for addressing bacterial overgrowth, enzyme insufficiencies, leaky gut, and immune dysregulation using diet, botanicals, and targeted supplementation.
• Case-based guidance on integrating GI360™ insights into personalized treatment plans, progress tracking, and long-term gut healing strategies.
• Engage in 6 live Q&A sessions with the Doctor's Data team!

The first live session is on Thursday, July 24th, 2025. We hope to see you there!

This event is hosted by Rupa University, a Fullscript company.